A bill to decriminalize drug possession has been introduced into Congress. If passed, jurisdiction for drug classifying would move from the Justice Department to the Department of Health and Human Services.

Read more

Red Light Holland and ASX-listed Creso Pharma are merging to form HighBrid Lab. TRIP CEO Todd Shapiro to lead the combined entity.

Read more
Cybin Selects Anxiety Disorder Indications for Proprietary Psychedelic Molecule CYB004

Cybin’s latest R&D initiative (CYB004) is a proprietary molecule targeting anxiety disorders.

Read more
Mydecine Unveils Artificial Intelligence Drug Discovery Program

Mydecine announces a new program to incorporate AI “machine learning” into its drug R&D.

Read more
Bright Minds Biosciences Announces Application to List on Nasdaq

Bright Minds Biosciences has applied to uplist to the NASDAQ.

Read more

Read more
British Columbia Government Urges Cannabis Consumers to Use Legal Market

The British Columbia, Canada government is urging cannabis consumers to purchase legal cannabis after finding contaminants in confiscated unregulated cannabis, Marijuana Business Daily reports.

Read more
‘I’m a lighter me’: Can Mike Tyson and psychedelics help boxers with brain trauma?

The former heavyweight champion says psychedelics would have helped him with his mental health during his career. Some scientists and companies agree

Read more
Atai To Upsize IPO Financing To $246 Million, The Industry Leader Just Got Bigger

Atai Life Sciences has re-filed with the SEC to increase its IPO financing from $100 to $246 million. It’s a big deal.

Read more
Are Psychedelics The Ultimate Brain-Repair Drugs?

Psychedelic drugs increasingly appear to be powerful medicinal tools to rebuild broken brains.

Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )